We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tufts: Drugmakers Must Navigate Greater Trial Complexity, Lower Approval Rates to Survive
Tufts: Drugmakers Must Navigate Greater Trial Complexity, Lower Approval Rates to Survive
Drugmakers need to better connect their clinical and R&D operations to cope with the growing cost and complexity of clinical trials amidst declining drug approvals.